Recurrent chemical pregnancies usually point to a problem with the embryo, the uterine lining, or the hormonal environment needed to sustain early implantation. A chemical pregnancy happens when an embryo begins to implant and produces enough pregnancy hormone (hCG) to turn a test positive, but stops developing before a gestational sac ever becomes visible on ultrasound. Your period arrives close to on time, sometimes just a few days late, and the only evidence the pregnancy existed is that faint positive test.
One chemical pregnancy is extremely common and rarely signals an underlying issue. But when it happens two, three, or more times in a row, there are several specific causes worth investigating.
What Makes a Chemical Pregnancy Different
The pregnancy hormone hCG can be detected in blood as early as seven days after ovulation, and a positive test after 12 days is generally considered a real pregnancy signal. In a chemical pregnancy, hCG rises briefly but never climbs high enough or long enough to support continued development. There is no gestational sac on ultrasound, and bleeding starts within days of the missed period. Some clinicians require two consecutive rising hCG values before calling it a true biochemical pregnancy, since a single elevated reading can be an isolated spike that doesn’t represent implantation at all.
The distinction matters because a chemical pregnancy means fertilization and at least partial implantation did occur. Your body can conceive. The breakdown is happening in the days immediately after the embryo attaches to the uterine wall.
Chromosomal Problems in the Embryo
The most common reason any early pregnancy fails is that the embryo has the wrong number of chromosomes. Roughly half of all miscarriages are caused by this kind of genetic error, called aneuploidy, where an embryo ends up with extra or missing chromosomes during fertilization. These errors are largely random, but they become much more frequent as egg quality declines with age.
The risk of miscarriage is lowest for women aged 25 to 29, sitting around 10%. It climbs steadily after that, reaching over 53% for women 45 and older. If you’re experiencing repeated chemical pregnancies in your late 30s or 40s, the statistical likelihood is that chromosomally abnormal embryos are the primary driver. Both partners contribute genetic material, so parental chromosome testing (called a karyotype) is one of the first steps in a recurrent loss workup. Most of the time, parental chromosomes are normal and the errors are happening spontaneously during cell division in the egg or early embryo.
Hormonal Gaps That Prevent Implantation
After ovulation, the structure left behind on the ovary (the corpus luteum) produces progesterone, which transforms the uterine lining into a receptive environment for an embryo. If progesterone output is too low or doesn’t last long enough, the lining can begin to break down before the embryo has time to establish itself. This is called luteal phase deficiency.
A luteal phase shorter than 10 days is one clinical marker. Another is a midcycle progesterone level below 5 ng/mL. But the issue isn’t always about how much progesterone the ovary produces. In some cases, the uterine lining itself has a blunted response to normal progesterone levels, a form of progesterone resistance that makes the lining inhospitable even when blood levels look adequate. Conditions that disrupt the hormonal signals from the brain to the ovary, such as thyroid disorders, high prolactin, or significant stress, can also impair the corpus luteum and shorten the window for implantation.
Progesterone supplementation is one of the more straightforward interventions, though its effectiveness depends on whether the problem is truly low production versus poor endometrial response.
Immune and Clotting Disorders
Antiphospholipid syndrome (APS) is one of the few immune conditions with a well-established link to recurrent pregnancy loss. In APS, the immune system produces antibodies that interfere with the earliest stages of placental development. These antibodies block the cells that would normally burrow into the uterine wall and form the blood supply between mother and embryo. They also trigger inflammation at the implantation site and can cause tiny blood clots in the developing placental tissue.
The result is an embryo that implants but quickly loses its connection to the mother’s blood supply. Testing for antiphospholipid antibodies is a standard part of the evaluation after recurrent losses. A confirmed diagnosis of APS is one of the most treatable causes: blood-thinning medication during pregnancy significantly improves outcomes.
Uterine Shape and Structural Issues
An irregularly shaped uterus increases the odds of early miscarriage. This includes a uterine septum (a wall of tissue dividing the cavity), polyps, or fibroids that distort the inner lining. These structural problems can prevent the embryo from implanting in an area with adequate blood flow, or they can create a lining that doesn’t develop evenly.
Many of these issues are detectable with imaging. A saline-infusion sonogram or hysteroscopy gives a detailed view of the uterine cavity. Some structural problems, like a septum or polyps, can be corrected surgically, which may improve implantation rates in subsequent pregnancies.
Sperm DNA Damage
The male partner’s contribution matters more in early loss than many people realize. Sperm carry half the embryo’s DNA, and when that DNA is fragmented or damaged, the embryo may fertilize and begin dividing but fail in its earliest stages. Oxidative stress, infections, heat exposure, smoking, and age can all increase sperm DNA fragmentation.
Damaged sperm DNA can also impair development of the placental cells, leading to inadequate placental function even before the pregnancy is clinically visible. A DNA fragmentation index (DFI) above 30% is considered severe in most studies. That said, research on whether high DFI directly causes recurrent loss is mixed. A 2024 study of nearly 1,500 couples found no statistically significant difference in sperm DNA fragmentation between those with recurrent loss and those without. The connection likely depends on how severe the damage is and whether other factors are also at play.
If the female partner’s workup comes back normal, a semen analysis with DNA fragmentation testing is a reasonable next step.
What Testing Looks Like
Most reproductive specialists will begin a formal evaluation after two consecutive losses, though some wait until three. The standard workup typically includes:
- Karyotype for both partners, checking for chromosomal rearrangements that increase the chance of abnormal embryos
- Antiphospholipid antibody panel, tested twice at least 12 weeks apart to confirm a true positive
- Thyroid function and prolactin levels, since both can impair ovulation and luteal phase quality
- Progesterone testing in the second half of the cycle to assess luteal function
- Uterine imaging, usually a sonogram with saline or a hysteroscopy to look for structural abnormalities
If you’re undergoing IVF, preimplantation genetic testing of embryos can identify chromosomal errors before transfer, which reduces the chance of chemical pregnancy significantly.
Why the Outlook Is Better Than It Feels
Repeated chemical pregnancies are emotionally draining, especially because they happen so early that the loss can feel invisible to everyone else. But a chemical pregnancy does confirm one important thing: your body can fertilize an egg and begin implantation. That places you in a fundamentally different category than someone who isn’t conceiving at all.
For many people, the cause turns out to be identifiable and treatable. Correcting a short luteal phase, treating APS, removing a polyp, or selecting chromosomally normal embryos through IVF can each meaningfully shift the odds. Even among couples where no specific cause is found, the majority go on to have a successful pregnancy. The uncertainty is real, but the biology is often on your side.